Revolution Medicines, Inc. (NASDAQ:RVMDW) Sees Significant Increase in Short Interest

Revolution Medicines, Inc. (NASDAQ:RVMDW – Get Free Report) was the target of a large growth in short interest during the month of August. As of August 31st, there was short interest totaling 2,000 shares, a growth of 139.2% from the August 15th total of 836 shares. Based on an average daily trading volume, of 54,704 shares, the days-to-cover ratio is currently 0.0 days.

Revolution Medicines Price Performance

NASDAQ RVMDW traded down $0.47 during trading hours on Tuesday, reaching $10.97. The company’s stock had a trading volume of 944 shares, compared to its average volume of 108,229. The company’s 50-day moving average is $10.65 and its two-hundred day moving average is $6.73. Revolution Medicines has a fifty-two week low of $0.22 and a fifty-two week high of $13.44.

Revolution Medicines Company Profile

(Get Free Report)

Revolution Medicines (NASDAQ:RVMDW) is a clinical-stage oncology company focused on discovering and developing small-molecule therapies that target the RAS signaling pathway. The company’s scientific approach centers on designing molecules that selectively inhibit mutant RAS proteins and key regulators of RAS-driven cancers, with the goal of addressing tumor types that have historically been resistant to targeted therapies.

Revolution Medicines has advanced multiple pipeline candidates into clinical trials, including RMC-4630, a selective SHP2 inhibitor, and RMC-6236, an oral pan-RAS inhibitor designed to block signaling from multiple RAS mutants.

Further Reading

• Five stocks we like better than Revolution Medicines
• Could Dave & Buster’s Capitulation Signal the Bottom Is Finally In?
• A Sub-20 P/E on GOOGL? The Market May Be Missing Something
• SpaceX Defies Gravity With a Nasdaq-100 Double-Weighting Boost
• Navan’s Strong Quarter Meets an AI Spending Reality Check